US Patent

US9388159 — Substituted diazaspiroalkanes as androgen receptor modulators

Composition of Matter · Assigned to University of California San Diego UCSD · Expires 2027-03-27 · 1y remaining

Vulnerability score 30/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects novel compounds that are androgen receptor modulators useful for treating androgen receptor-associated conditions.

USPTO Abstract

This invention provides for compounds of the Formula II: wherein A, B, Het, R 1 , R 2 and R 3 are as described herein. These compounds are androgen receptor modulators useful for the treatment of androgen receptor-associated conditions.

Drugs covered by this patent

Patent Metadata

Patent number
US9388159
Jurisdiction
US
Classification
Composition of Matter
Expires
2027-03-27
Drug substance claim
Yes
Drug product claim
Yes
Assignee
University of California San Diego UCSD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.